FilingSEC EDGAR8-K
Allarity Therapeutics Granted Key Diagnostic Patent in Japan
· SEC accepted
StagePatent Grant
Filing content
The company received a Japanese patent for its stenoparib DRP® companion diagnostic, providing protection through 2039.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…